Masao Iwata

2.1k total citations · 1 hit paper
13 papers, 1.6k citations indexed

About

Masao Iwata is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Masao Iwata has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Organic Chemistry. Recurrent topics in Masao Iwata's work include Cancer, Hypoxia, and Metabolism (3 papers), RNA modifications and cancer (3 papers) and RNA Research and Splicing (3 papers). Masao Iwata is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), RNA modifications and cancer (3 papers) and RNA Research and Splicing (3 papers). Masao Iwata collaborates with scholars based in Japan and United States. Masao Iwata's co-authors include Kiyoshi Okamoto, Yoshiharu Mizui, Kotaro Kodama, Hajime Shimizu, Yoshihiko Kotake, Koji Sagane, Yasushi Ishihama, Yukinori Minoshima, Takashi Owa and Mai Uesugi and has published in prestigious journals such as Cancer Research, Nature Chemical Biology and Cancer Letters.

In The Last Decade

Masao Iwata

13 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Splicing factor SF3b as a target of the antitumor natural product pladienolide

2007 500 citations Yoshihiko Kotake, Koji Sagane et al. Nature Chemical Biology profile →

Peers

Masao Iwata

MB

ONCOL

CR

PRM

EDM

Toshimitsu Uenaka Japan

Yukinori Minoshima Japan

Gareth Hughes United Kingdom

Jessica Orf United States

Teresa Di Desidero Italy

Brenda J Curry United Kingdom

Fawn Qian United States

Anna Fioravanti Italy

Carolyn Sidor United States

Paula Kaplan‐Lefko United States

Toshimitsu Uenaka Japan

Masao Iwata

797 ×0.8

MB

652 ×2.2

ONCOL

258 ×1.2

CR

509 ×2.4

PRM

233 ×1.3

EDM

Citations per year, relative to Masao Iwata Masao Iwata (= 1×) peers Toshimitsu Uenaka

Countries citing papers authored by Masao Iwata

Since Specialization

Citations

This map shows the geographic impact of Masao Iwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masao Iwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masao Iwata more than expected).

Fields of papers citing papers by Masao Iwata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masao Iwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masao Iwata. The network helps show where Masao Iwata may publish in the future.

Co-authorship network of co-authors of Masao Iwata

This figure shows the co-authorship network connecting the top 25 collaborators of Masao Iwata. A scholar is included among the top collaborators of Masao Iwata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masao Iwata. Masao Iwata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Ito, Ken, Shusei Hamamichi, Makoto Asano, et al.. (2016). ¹¹¹ In‐encapsulated liposome‐distribution in mouse xenografts of human ovarian cancer. Cancer Science. 107(1). 1–1. 1 indexed citations

2.

Ito, Ken, Shusei Hamamichi, Makoto Asano, et al.. (2015). Radiolabeled liposome imaging determines an indication for liposomal anticancer agent in ovarian cancer mouse xenograft models. Cancer Science. 107(1). 60–67. 25 indexed citations

3.

Narita, Yusuke, Kiyoshi Okamoto, Kazuma Takase, et al.. (2014). Novel ATP-Competitive MEK Inhibitor E6201 Is Effective against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model. Molecular Cancer Therapeutics. 13(4). 823–832. 23 indexed citations

4.

Tohyama, Osamu, Junji Matsui, Kotaro Kodama, et al.. (2014). Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models. Journal of Thyroid Research. 2014. 1–13. 362 indexed citations

5.

Okamoto, Kiyoshi, Kotaro Kodama, Kazuma Takase, et al.. (2013). Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models. Cancer Letters. 340(1). 97–103. 237 indexed citations

6.

Sato, Momoko, Naoki Muguruma, Tadahiko Nakagawa, et al.. (2013). High antitumor activity of pladienolide B and its derivative in gastric cancer. Cancer Science. 105(1). 110–116. 45 indexed citations

7.

Yokoi, Akira, Yoshihiko Kotake, Kentaro Takahashi, et al.. (2011). Biological validation that SF3b is a target of the antitumor macrolide pladienolide. FEBS Journal. 278(24). 4870–4880. 140 indexed citations

8.

Iwata, Masao, Toshimitsu Uenaka, Yoichi Ozawa, et al.. (2007). E7107: Antitumor activity on human SCLC and cervical cancer xenografts in relation to its potential predictive markers of response.. Cancer Research. 67. 5608–5608. 1 indexed citations

9.

Kotake, Yoshihiko, Koji Sagane, Takashi Owa, et al.. (2007). Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nature Chemical Biology. 3(9). 570–575. 500 indexed citations breakdown →

10.

Niijima, Jun, Yoshihiko Kotake, Mitsuo Nagai, et al.. (2004). E7107, a new 7-urethane derivative of pladienolide D: Discovery of a novel antitumor agent. Cancer Research. 64. 691–691. 18 indexed citations

11.

Mizui, Yoshiharu, Takashi Sakai, Masao Iwata, et al.. (2004). Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 III. In Vitro and In Vivo Antitumor Activities. The Journal of Antibiotics. 57(3). 188–196. 163 indexed citations

12.

Furuyama, Akiko, Masao Iwata, Toshihiko Hayashi, & Katsumi Mochitate. (1999). Transforming growth factor-β1 regulates basement membrane formation by alveolar epithelial cells in vitro. European Journal of Cell Biology. 78(12). 867–875. 19 indexed citations

13.

Iwata, Masao, et al.. (1995). Evidence for a Short Form of α1(IV) as a Major Polypeptide in Bovine Lens Capsule. The Journal of Biochemistry. 117(6). 1298–1304. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact